Representative Director

Representative Director Yukio Takene

J-ARM was launched in 2006 as a venture company originating from Nagoya University, and began providing veterinary hospitals with immune cell culture kits in 2008 and adipose tissue-derived mesenchymal stem cell culture kits in 2010.

Currently, we offer more than 10 types of cell culture kits, mainly for canine and feline cells, and equipment that enables safe culture even in limited space.

In addition, culture training is provided to improve techniques and knowledge of animal cell culture.

One of J-ARM’s most important roles is the compilation of clinical cases performed at partner veterinary hospitals and their feedback. In addition, J-ARM provides daily consultation services on culture, scientific verification of the quality of cultured cells, and safety testing.

J-ARM has developed a kit to ensure safe, simple, and sufficient quality and number of cells at the facilities where regenerative medicine is performed. J-ARM is a kit that ensures safe, simple, and sufficient quality and cell numbers at facilities where regenerative medicine is performed.

Based on the culture technology and knowledge we have cultivated, we are
・developing new kits with higher proliferative potential and easier to use
・developing veterinary cell medicine based on clinical cases
・spreading veterinary regenerative medicine to Asian countries.

We hope to contribute to the development of veterinary regenerative medicine by providing such animal cell culture kits and feedback on clinical cases in which they are used.

Now, our goal at J-ARM is to help “people and their companion animals that have become “family members” achieve a healthy life together.”